Physician profile
Kenneth L Howe
NPI 1932100245
$6,722.46
in general payments reported to CMS, 2019-2025
17 companies · $404 in 2025
The $404 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.82 · 2020: $63.00 · 2021: $187 · 2022: $154 · 2023: $5,688 · 2024: $153 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $745.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $5,500.00 | 2023 | |
| Abbvie INC. | $283.98 | 2023-2025 | |
| Allergan, INC. | $150.31 | 2021-2022 | |
| Leo Pharma INC. | $120.87 | 2025 | Anzupgo, Adbry |
| Mayne Pharma Commercial LLC | $113.73 | 2020-2025 | |
| Almirall LLC | $108.61 | 2021-2025 | Seysara |
| Galderma Laboratories, L.P. | $103.79 | 2019-2022 | |
| Arcutis Biotherapeutics, INC. | $91.14 | 2024-2025 | Zoryve |
| Incyte Corporation | $75.04 | 2024-2025 | Opzelura |
| Encore Dermatology INC. | $38.44 | 2019 | |
| Epi Health, LLC | $32.59 | 2020-2021 | |
| Dermavant Sciences, INC. | $25.48 | 2024 | Vtama |
| Journey Medical Corporation | $17.67 | 2025 | |
| Sun Pharmaceutical Industries INC. | $17.08 | 2021 | |
| Botanix Sb INC | $15.36 | 2025 | Sofdra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.40 | 2021 | |
| Sebela Pharmaceuticals INC. | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.